Yinghong Yu

Mr. Yinghong Yu


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
YYYinghong Yu
Yinghong Yu
Shi YeShi Ye
Shi Ye
ZXZihao Xia
Zihao Xia
Hao LuoHao Luo
Hao Luo
Liyong MaLiyong Ma
Liyong Ma
Objectives: Accurate severity classification is important for sensor-based assessment of Parkinson’s disease, but overlap between adjacent stages and class imbalance can reduce model robustness. This study aimed to develop and evaluate a dual-task gait fusion framework that integrates signals collected during self-selected walking and walking with turning. Methods: The primary cohort comprised 87 participants with Parkinson’s disease across mild, mild-to-moderate, and moderate stages. Task-specific temporal representations were learned from the two gait conditions, concatenated and optimized using delayed class re-weighting. Performance was evaluated using subject-level stratified five-fold cross-validation with five random seeds. Generalizability was further assessed using an independent PhysioNet cohort of 93 participants with Parkinson’s disease. Results: The proposed method achieved an accuracy of 90.23 ± 1.27, balanced accuracy of 89.61 ± 1.13, macro F1-score of 89.10 ± 1.35, and probability-based macro AUC of 94.43 ± 1.42 on WearGait-PD. Confusion matrix and ablation analyses indicated balanced class-level performance and complementary contributions from dual-task fusion and delayed re-weighting. On the external PhysioNet cohort, accuracy, balanced accuracy, macro F1-score, and macro AUC were 84.34 ± 1.82, 82.13 ± 1.92, 81.68 ± 1.98, and 88.93 ± 2.14, respectively. Conclusions: Integrating turning-related gait information with self-selected walking signals improved wearable sensor-based severity classification and showed cross-dataset robustness, although validation in larger cohorts with complete severity stage coverage remains necessary.